线粒体移植:揭开眼睛疾病有前途的治疗方法
Yan Zhuang Yeo1, Mayuri Bhargava2, Rajvinder Singh Khare1
1Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), 1E Kent Ridge Road, NUHS Tower Block Level 7, Singapore, 119228, Singapore; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
Redox biology
|October 31, 2025
概括
线粒体移植 (MT) 提供了一种新的方法,通过增强细胞功能来治疗代谢性眼病. 本综述探讨了这种有前途的治疗方法的眼部应用,挑战和未来方向.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 代谢疾病 代谢疾病
背景情况:
- 线粒体移植 (MT) 涉及转移健康的线粒体以改善细胞功能.
- 最初用于抗生素耐药性,MT现在针对各种疾病中的代谢功能障碍.
- 眼睛代谢障碍是导致眼睛疾病发病的重要因素.
研究的目的:
- 在眼睛疾病的背景下审查线粒体生物学.
- 总结眼睛线粒体移植目前的进展.
- 讨论眼科中MT的挑战和未来前景.
主要方法:
- 关于线粒体生物学和眼部疾病的文献综述.
- 对眼科中线粒体移植的当前研究进行分析.
- 确定临床翻译的瓶.
主要成果:
- 在治疗角膜,视神经和视网膜疾病方面,MT显得有前途.
- 在其他器官 (心脏,肺,大脑) 中成功应用MT鼓励眼部使用.
- 疗法治疗是一种新兴的治疗策略,有可能产生重大影响.
结论:
- 线粒体移植是治疗各种眼部疾病的一种有前途的疗法.
- 为了使MT成为标准的临床实践,必须克服几个挑战.
- 需要进一步的研究来推进眼部MT从"长椅到床边".
相关概念视频
Tissue Transplantation
885
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
885
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


